🇺🇸 FDA

Intelligence · Clinical Pipeline

Hospital Authority Pipeline

All ClinicalTrials.gov programs at Hospital Authority — phase, modality, and trial IDs.

Programs
322

Quick answer

Hospital Authority has 322 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. 1 apical pleurectomy

    Hospital Authority, Hong Kong

    Pneumothorax

    phase 3 other active

    1 trial

  2. AST-120and pentoxyphylline (PTX)

    Hospital Authority, Hong Kong

    Acute Kidney Injury

    phase 3 small molecule active

    1 trial

  3. Autologous Peripheral Blood Stem Cell injection

    Hospital Authority, Hong Kong

    Acute Myocardial Infarction

    phase 3 mab active

    1 trial

  4. Bacillus Calmette Guerin and interferon alpha

    Hospital Authority, Hong Kong

    Carcinoma of Urinary Bladder, Superficial

    phase 3 small molecule completed

    1 trial

  5. Barley beta-glucan(3.0g)

    Hospital Authority, Hong Kong

    Overweight; Hyperlipidemia

    phase 3 other completed

    1 trial

  6. Bevacizumab

    Hospital Authority, Hong Kong

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  7. Bortezomib

    Hospital Authority, Hong Kong

    Multiple Myeloma

    phase 3 small molecule active

    1 trial

  8. Botulinum toxin type A

    Hospital Authority, Hong Kong

    Obesity

    phase 3 small molecule active

    1 trial

  9. Cannabidiol Oil

    Hospital Authority, Hong Kong

    Dementia, Vascular

    phase 3 small molecule active

    1 trial

  10. Capecitabine plus temozolamide

    Hospital Authority, Hong Kong

    Neuroendocrine Neoplasia's (NENs)

    phase 3 small molecule active

    1 trial

  11. Champix

    Hospital Authority, Hong Kong

    Tobacco Use Disorder

    phase 3 small molecule completed

    1 trial

  12. Control

    Hospital Authority, Hong Kong

    Hallucinations, Verbal Auditory

    phase 3 small molecule active

    1 trial

  13. Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF

    Hospital Authority, Hong Kong

    Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  14. Dexmedetomidine Hcl 100 Mcg/mL Inj

    Hospital Authority, Hong Kong

    Congenital Heart Disease in Children

    phase 3 small molecule completed

    1 trial

  15. Dienogest

    Hospital Authority, Hong Kong

    Endometriosis

    phase 3 small molecule active

    1 trial

  16. Doxycycline

    Hospital Authority, Hong Kong

    Tuberculosis

    phase 3 small molecule active

    1 trial

  17. Empagliflozin 10 MG

    Hospital Authority, Hong Kong

    Diabetic Nephropathies

    phase 3 small molecule terminated

    1 trial

  18. Eriobotyra Japonica Lindley Extract

    Hospital Authority, Hong Kong

    Cognitive Function

    phase 3 other completed

    1 trial

  19. Finished Herbal Product such as Suan Tsao Jen Tang, Jia-Wey Shiau-Yau San

    Hospital Authority, Hong Kong

    Menopausal Women

    phase 3 small molecule active

    1 trial

  20. Flublok Quadrivalent vaccine

    Hospital Authority, Hong Kong

    Influenza Vaccination

    phase 3 mab completed

    1 trial

  21. Formosa 1-Breath Free (NRICM101)

    Hospital Authority, Hong Kong

    Influenza Viral Infections

    phase 3 small molecule active

    1 trial

  22. Fractional CO2 Laser

    Hospital Authority, Hong Kong

    Treatments of Striae Gravidarum

    phase 3 other active

    1 trial

  23. GCSF

    Hospital Authority, Hong Kong

    End Stage Liver Disease

    phase 3 small molecule active

    1 trial

  24. Intravenous methylene blue administration

    Hospital Authority, Hong Kong

    Severe Sepsis

    phase 3 small molecule active

    1 trial

  25. Intravenous thrombolysis plus tirofiban

    Hospital Authority, Hong Kong

    Acute Ischemic Stroke

    phase 3 small molecule completed

    1 trial

  26. L-alanyl-L-glutamine dipeptide

    Hospital Authority, Hong Kong

    Coronary Artery Bypass

    phase 3 small molecule completed

    1 trial

  27. LC-1000

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    phase 3 other completed

    1 trial

  28. Microfracture

    Hospital Authority, Hong Kong

    Other Articular Cartilage Disorders

    phase 3 other active

    1 trial

  29. Mifepristone

    Hospital Authority, Hong Kong

    Miscarriage

    phase 3 small molecule completed

    1 trial

  30. Online HDF

    Hospital Authority, Hong Kong

    End Stage Renal Disease

    phase 3 other completed

    1 trial

  31. Oral dexamethasone

    Hospital Authority, Hong Kong

    Bronchiolitis

    phase 3 small molecule completed

    1 trial

  32. Oral immunonutrition

    Hospital Authority, Hong Kong

    Non Small Cell Lung Cancer

    phase 3 other active

    1 trial

  33. PBSCs

    Hospital Authority, Hong Kong

    Hematological Malignancies

    phase 3 other completed

    1 trial

  34. PEG-interferon-Alfa-2A

    Hospital Authority, Hong Kong

    Chronic Hepatitis B

    phase 3 small molecule active

    1 trial

  35. Pantoprazole (Pantoloc)

    Hospital Authority, Hong Kong

    Peptic Ulcers

    phase 3 small molecule active

    1 trial

  36. Pemetrexed 500mg/m2 iv

    Hospital Authority, Hong Kong

    NSCLC

    phase 3 small molecule active

    1 trial

  37. Placebo

    Hospital Authority, Hong Kong

    Congenital Heart Disease in Children

    phase 3 small molecule completed

    1 trial

  38. Platelet Rich Plasma

    Hospital Authority, Hong Kong

    Severe Oligoasthenoteratozoospermia

    phase 3 mab completed

    1 trial

  39. Progesterone supplementation

    Hospital Authority, Hong Kong

    Assisted Reproductive Technology

    phase 3 other active

    1 trial

  40. Rifaximin

    Hospital Authority, Hong Kong

    Decompensated Cirrhosis

    phase 3 small molecule terminated

    1 trial

  41. Rituximab

    Hospital Authority, Hong Kong

    Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

    phase 3 mab completed

    1 trial

  42. Sodium tetradecyl sulfate

    Hospital Authority, Hong Kong

    Gastric Varices Bleeding

    phase 3 small molecule active

    1 trial

  43. Tacrolimus

    Hospital Authority, Hong Kong

    Graft vs Host Disease

    phase 3 small molecule completed

    1 trial

  44. Taping and Sham Taping

    Hospital Authority, Hong Kong

    Stroke

    phase 3 other completed

    1 trial

  45. Taxotere , Epirubicin

    Hospital Authority, Hong Kong

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  46. Tenecteplase

    Hospital Authority, Hong Kong

    Ischemic Stroke

    phase 3 small molecule active

    1 trial

  47. Terazosin

    Hospital Authority, Hong Kong

    Stent Related Symptoms

    phase 3 small molecule active

    1 trial

  48. Vitamin D3

    Hospital Authority, Hong Kong

    Lupus Erythematosus, Systemic

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Hospital Authority have?

322 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.